ObesityNCT06913231
Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students
A study testing Whole body vibration device in people with Obesity and Overweight, run by Cairo University at 1 site in Saudi Arabia.
Trial summary
Obesity has become a significant public health concern globally, particularly among university students, where lifestyle changes contribute to increased body weight and fat accumulation. Read more about this study
- Who is it for?
- Ages 18 to 25 years
- Conditions the study is for
- Obesity, Overweight
- What is being tested?
- Whole body vibration device
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 32 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 6 Apr 2025to 18 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Male and female University students with BMI ≥ 25, and their age between 18-25 years.
Who cannot join
- Musculoskeletal, neurological and cardiovacular conditionds,in addition to pregnancy and insrtion of pacemekers or other metal implants.
Trial locations and contacts
1 site in 1 country.
Saudi Arabia1 site
College of Applied Medical Sciences, Jouf University
Jouf, Sakaka
About this study
Official title: Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students: A Randomized Controlled Trial
Obesity has become a significant public health concern globally, particularly among university students, where lifestyle changes contribute to increased body weight and fat accumulation. The World Health Organization defines obesity as a condition characterized by excessive fat accumulation that presents a risk to health, with a body mass index (BMI) of 30 or higher being a common threshold for classification. In Saudi Arabia, the prevalence of obesity among young adults is alarming, necessitating effective interventions to combat this issue.
- Conditions
- Obesity, Overweight
- Being tested
- Whole body vibration device, Sham Whole body vibration
- Medical subject headings
- Obesity, Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Whole body vibration deviceDevice
Whole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA). The vibration frequency was set between 30-40 Hz, with an amplitude of 2-4 mm.
Sham Whole body vibrationOther
A sham Whole body vibration will be used . participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform.
| Study group | Role | What they receive |
|---|---|---|
| Study group | Experimental | The study group (no = 16) underwent whole-body vibration (WBV) training using the PowerPlate device. Sessions will be conducted three times per week for 6 weeks. Receives: Device: Whole body vibration device |
| Control group | Sham comparator | The sham WBV group (no=16) will stand on the same device with the vibtation shut off. Sessions will be conducted three times per week for 6 weeks. Receives: Other: Sham Whole body vibration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Mass Index
BMI will be calculated as weight (kg) divided by height (m²).
Measured: 6 weeks
Waist circumference
WC will be measured at the midpoint between the lower rib and iliac crest using a non-stretchable measuring tape.
Measured: 6 weeks
Secondary outcomes (3)
Body fat percentage
A smart scale will be used to measure body composition including the percentage of whole bofy fat.
Measured: 6 weeks
Visceral mass
Visceral fat will be assesed also using the same smart scale using the bioelectrical impedance analysis.
Measured: 6 weeks
Lean body mass
bioelectrical impedance analysis will be also used via a smart scale to measure the total lean body mass in (kg).
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2025
- Study start6 Apr 2025
- Primary completion6 Jun 2025
- Study completion18 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rokaia Ali Zainelabedeen Mohamed Toson, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06913231
- Sponsor's protocol ID
- 7586
- Status last verified
- Nov 2025
- First submitted
- 30 Mar 2025
- Last updated
- 3 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Toson RA, Al-Ruwailiy K, Al-Sarhany R, Ali ZA, Alsirhani H, Kashif N, Mohamed RA, Abd-Eltawab AE, Alowaydhah S, Sarhan EE, Shukry M, Elnashar EM, Alshehri HH, Al-Serwi RH, Abdelrahman MMA, Allam NM. Impact of whole-body vibration on anthropometric measurements and body composition in overweight and obese university students: a randomized controlled trial. Front Med (Lausanne). 2026 Jun 11;13:1814883. doi: 10.3389/fmed.2026.1814883. eCollection 2026.
PubMed 42369152
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Whole-Body Vibration on Anthropometric Measurement and Body Composition in Overweight and Obese University Students: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06913231
- Acronym / sponsor ID
- 7586
- Conditions
- Obesity, Overweight
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 6 Apr 2025 (actual)
- Primary completion
- 6 Jun 2025 (actual)
- Study completion
- 18 Aug 2025 (actual)
- First posted
- 6 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Obesity has become a significant public health concern globally, particularly among university students, where lifestyle changes contribute to increased body weight and fat accumulation. The World Health Organization defines obesity as a condition characterized by excessive fat accumulation that presents a risk to health, with a body mass index (BMI) of 30 or higher being a common threshold for classification. In Saudi Arabia, the prevalence of obesity among young adults is alarming, necessitating effective interventions to combat this issue.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Study group | Experimental | Device: Whole body vibration deviceThe study group (no = 16) underwent whole-body vibration (WBV) training using the PowerPlate device. Sessions will be conducted three times per week for 6 weeks. |
| Control group | Sham comparator | Other: Sham Whole body vibrationThe sham WBV group (no=16) will stand on the same device with the vibtation shut off. Sessions will be conducted three times per week for 6 weeks. |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Male and female University students with BMI ≥ 25, and their age between 18-25 years.
Key exclusion criteria (1 listed)
- Musculoskeletal, neurological and cardiovacular conditionds,in addition to pregnancy and insrtion of pacemekers or other metal implants.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Whole body vibration deviceWhole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA). The vibration frequency was set between 30-40 Hz, with an amplitude of 2-4 mm. | Device | Study group |
| Sham Whole body vibrationA sham Whole body vibration will be used . participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform. | Other | Control group |
Primary outcome
Body Mass Index
Time frame: 6 weeks
BMI will be calculated as weight (kg) divided by height (m²).
Waist circumference
Time frame: 6 weeks
WC will be measured at the midpoint between the lower rib and iliac crest using a non-stretchable measuring tape.
3 secondary outcomes
Body fat percentage
Time frame: 6 weeks
Visceral mass
Time frame: 6 weeks
Lean body mass
Time frame: 6 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2025.
- Derived from this study: PubMed 42369152Toson RA, Al-Ruwailiy K, Al-Sarhany R, Ali ZA, Alsirhani H, Kashif N, Mohamed RA, Abd-Eltawab AE, Alowaydhah S, Sarhan EE, Shukry M, Elnashar EM, Alshehri HH, Al-Serwi RH, Abdelrahman MMA, Allam NM. Impact of whole-body vibration on anthropometric measurements and body composition in overweight and obese university students: a randomized controlled trial. Front Med (Lausanne). 2026 Jun 11;13:1814883. doi: 10.3389/fmed.2026.1814883. eCollection 2026.
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Whole body vibration device in people with Obesity and Overweight, run by Cairo University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Mass Index (time frame: 6 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06913231, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2025.